Location History:
- Bellevue, WA (US) (2001)
- Carnation, WA (US) (2003 - 2011)
Company Filing History:
30 out of 247 
2 out of 1,552 
1 out of 1 Years Active: 2001-2011
Title: Marc W. Retter: Pioneering Cancer Treatments and Diagnostics Innovator
Introduction:
Marc W. Retter, a distinguished scientist and inventor hailing from Carnation, WA, has significantly contributed to the field of cancer research and treatment. With an impressive portfolio of 31 patents, his groundbreaking work has revolutionized the fight against various types of cancer. This article delves into his latest patents, career highlights, notable collaborations, and the remarkable impact of his inventions.
Latest Patents:
One of Marc W. Retter's recent patents is centered around the development of antibodies to treat cancer. His invention, titled "Compositions and Methods for the Treatment of Cancer," focuses on melanoma, myeloma, small cell lung cancer, thymic lymphoma, T-cell lymphoma, B-cell lymphoma, osteosarcoma, and acute T-cell leukemia. The disclosed compositions encompass anti-ganglioside antibodies, including hamster antibodies, chimeric human/hamster antibodies, or humanized antibodies. These compositions have shown potential in inducing apoptosis in cancer cells and have promising implications for cancer treatment.
Another significant patent by Marc W. Retter relates to the therapy and diagnosis of ovarian cancer. Entitled "Compositions and Methods for the Therapy and Diagnosis of Cancer," this invention revolves around the inclusion of ovarian tumor polypeptides, immunogenic portions thereof, polynucleotides encoding these polypeptides, antigen-presenting cells expressing said polypeptides, and T cells specific to cells expressing these polypeptides. Such compositions present valuable opportunities for diagnosing, preventing, and treating ovarian cancer.
Career Highlights:
Throughout his illustrious career, Marc W. Retter has made profound contributions to various scientific institutions. He has notably worked with Corixa Corporation, a biotechnology company recognized for its groundbreaking research in immunotherapy. Additionally, Retter has played a pivotal role in advancing cancer research at the prestigious University of Massachusetts, further establishing himself as a prominent figure in the field.
Collaborations:
Marc W. Retter's accomplishments have been possible through collaborations with esteemed colleagues. Notably, he has worked alongside Gary R. Fanger and Thomas S. Vedvick, both renowned scientists who have made significant contributions to the field of cancer research. These fruitful collaborations have fostered an environment of innovation and knowledge sharing, leading to groundbreaking advancements in cancer treatment and diagnostics.
Conclusion:
Marc W. Retter's remarkable contributions in the realm of cancer treatment and diagnostics have paved the way for significant advancements in the field. His latest patents, involving the use of antibodies to treat cancer and the development of ovarian cancer-associated antibodies, exemplify his commitment to revolutionizing disease prevention and therapy. By joining forces with esteemed colleagues and working with renowned institutions, Retter has solidified his position as an exceptional inventor and a driving force in the fight against cancer.